Osiris Therapeutics (OSIR) Posts Narrower than Expected Q2 Loss of 13c/Share
Tweet
Share
E-mailGet Alerts OSIR Hot Sheet
Price: $18.99 --0%
Financial Fact:
Diluted earnings per share (in dollars per share): -0.02
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Diluted earnings per share (in dollars per share): -0.02
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Osiris Therapeutics (NASDAQ: OSIR) reported Q2 EPS of ($0.13), $0.02 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $1.63 million versus the consensus estimate of $1.57 million.
For earnings history and earnings-related data on Osiris Therapeutics (OSIR) click here.
For earnings history and earnings-related data on Osiris Therapeutics (OSIR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Omega Flex (OFLX) Tops Q2 EPS by 27c
- Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
